U.S. drugmakers and biotechs have come to rely on Chinese partners. Now, some of them are looking for alternatives as geopolitical tensions rise.
U.S. Drugmakers Are Breaking Up With Their Chinese Supply-Chain Partners
Related Posts
Allen nets shutout as Devils burn Oilers 3-0 – Edmonton | Globalnews.ca
November 5, 2024
9:38 am
Is higher inequality the price America pays for faster growth?
November 4, 2024
9:53 am
Auto & Transport Roundup: Market Talk
November 4, 2024
9:42 am